Mark C. Fishman, M.D., is President of the Novartis Institutes for BioMedical Research. He leads worldwide discovery and early clinical activities of Novartis, which aims to develop novel therapeutics for diseases. Prior to joining Novartis, Dr. Fishman was Professor of Medicine at Harvard Medical School, as well as Chief of Cardiology at the Massachusetts General Hospital and the founding Director of their Cardiovascular Research Center. Dr. Fishman is a Fellow of the American Academy of Arts and Sciences, and the Institutes of Medicine of the National Academies.
Mark Fishman
President of Novartis Institutes for BioMedical Research, Novartis
Participant In These Roundtable Discussions
Sat
May 11th
2013
May 11th
2013
Watch
Synthetic and Systems Biology: Reinventing the Code of Life
Synthetic biology, and its sister field systems biology, offers the means to reengineer DNA in ways (and at a pace) that Nature, in her evolutionary wisdom, never envisioned. Standing at the unique crossroads of biology, engineering, computer science and neuroscience, these emerging fields are working toward the development of novel drugs and energy sources, the... read more! »